Meanwhile, the number and activity of CD4+ helper T cells and CD8+ cytotoxic T cells are decreased in CML patients, manifested by up-regulation of surface markers such as PD-1 and CTLA-4, ultimately leading to a weakened immune response to CML cells (157). The gene discussed is CTLA4; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.